References
- Cowan CL Jr, Halder RM, Grimes PE, et al. Ocular disturbances in vitiligo. J Am Acad Dermatol 1986; 15: 17–24. doi:10.1016/S0190-9622(86)70136-9.
- Passeron T, Ortonne JP. Physiopathology and genetics of vitiligo [review]. J Autoimmun 2005; 25: S63–8. doi:10.1016/j.jaut.2005.10.001.
- Alikhan A, Felsten LM, Daly M, et al. Vitiligo: a comprehensive overview part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol 2011; 65: 473–491. doi:10.1016/j.jaad.2010.11.061.
- Taieb A, Alomar A, Böhm M, et al. Guidelines for the management of vitiligo: the European dermatology forum consensus. Br J Dermatol 2013; 168: 5–19. doi:10.1111/j.1365-2133.2012.11197.x.
- Albert DM, Wagoner MD, Pruett RC, et al. Vitiligo and disorders of the retinal pigment epithelium. Br J Ophthalmol 1983; 67: 153–156. doi:10.1136/bjo.67.3.153.
- Karadag R, Esmer O, Karadag AS, et al. Evaluation of ocular findings in patients with vitiligo. Int J Dermatol 2016; 55: 351–355. doi:10.1111/ijd.13031.
- Albert DM, Nordlund JJ, Lerner AB. Ocular abnormalities occurring with vitiligo. Ophthalmology 1979; 86: 1145–1160. doi:10.1016/S0161-6420(79)35413-6.
- Bulbul Baskan E, Baykara M, Ercan I, et al. Vitiligo and ocular findings: a study on possible associations. J Eur Acad Dermatol Venereol 2006; 20: 829–833. doi:10.1111/j.1468-3083.2006.01655.x.
- Perossini M, Turio E, Perossini T, et al. Vitiligo: ocular and electrophysiological findings. Ital Dermatol Venereol 2010; 145: 141–149.
- Aydin R, Ozsutcu M, Erdur SK, et al. The assessment of macular electrophysiology and macular morphology in patients with vitiligo. Int Ophthalmol 2018; 38: 233–239. doi:10.1007/s10792-017-0452-3.
- Riley PA. Melanin. Int J Biochem Cell Biology 1997; 29: 1235–1239. doi:10.1016/S1357-2725(97)00013-7.
- Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res 2010; 29: 144–168. doi:10.1016/j.preteyeres.2009.12.002.
- Demirkan S, Onaran Z, Samav G, et al. Decreased choroidal thickness in vitiligo patients. BMC Ophthalmol 2018; 18: 126. doi:10.1186/s12886-018-0796-0.
- Öncül H, Ayhan E. Retinal nerve fiber layer, retinal pigment epithelium, and choroidal thickness in vitiligo patients. J Cosmet Dermatol 2020; 19: 3032–3037. doi:10.1111/jocd.13367.
- Ma SH, Wu PC, Chang JY, et al. Ocular abnormalities in patients with vitiligo: a systematic review and meta-analysis. Dermatology 2022; 238: 813–822. doi:10.1159/000522601.
- Agrawal R, Salman M, Tan KA, et al. Choroidal vascularity index (CVI)–A novel optical coherence tomography parameter for monitoring patients with Panuveitis? PLoS ONE 2016; 11: e0146344. doi:10.1371/journal.pone.0146344.
- Cao J, McLeod S, Merges CA, et al. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol 1998; 116: 589–597. doi:10.1001/archopht.116.5.589.
- Sanchez-Cano A, Orduna E, Segura F, et al. Choroidal thickness and volume in healthy young white adults and the relationships between them and axial length, ammetropy and sex. Am J Ophthalmol 2014; 158: 574–583. doi:10.1016/j.ajo.2014.05.035.
- Yiu G, Chiu SJ, Petrou PA, et al. Relationship of central choroidal thickness with age-related macular degeneration status. Am J Ophthalmol 2015; 159: 617–626. doi:10.1016/j.ajo.2014.12.010.
- Fouad YA, Salman AG, Mohamed TH, et al. Assessment of the effect of vitiligo on subfoveal choroidal thickness using spectral-domain optical coherence tomography. Clin Ophthalmol 2020; 14: 2265–2270. doi:10.2147/OPTH.S255554.
- Ikuno Y, Kawaguchi K, Nouchi T, et al. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Visual Sci 2010; 51: 2173–2176. doi:10.1167/iovs.09-4383.
- Agrawal R, Gupta P, Tan KA, et al. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep 2016; 6: 21090. doi:10.1038/srep21090.